Cited by 1,733Renin-Angiotensin System StudiesEicosanoids and Hypertension PharmacologyCoagulation, Bradykinin, Polyphosphates, and Angioedema

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Crackower, Michael A., Sarao, Renu, Oudit, Gavin Y., Yagil, Chana, Kozieradzki, Ivona, Scanga, Sam E., Oliveira-dos-Santos, Antonio J., da Costa, Joan, Zhang, Liyong, Pei, York, Scholey, James, Ferrario, Carlos M., Manoukian, Armen S., Chappell, Mark C., Backx, Peter H., Yagil, Yoram, Penninger, Josef M.·2002·Nature

DOI 10.1038/nature00786

Open this paper in CoChat — free account

Abstract

Cardiovascular diseases are predicted to be the most common cause of death worldwide by 2020. Here we show that angiotensin-converting enzyme 2 (ace2) maps to a defined quantitative trait locus (QTL) on the X chromosome in three different rat models of hypertension. In all hypertensive rat strains, ACE2 messenger RNA and protein expression were markedly reduced, suggesting that ace2 is a candidate gene for this QTL. Targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart. Genetic ablation of ACE on an ACE2 mutant background completely rescues the cardiac phenotype. But disruption of ACER, a Drosophila ACE2 homologue, results in a severe defect of heart morphogenesis. These genetic data for ACE2 show that it is an essential regulator of heart function in vivo.

Integrity signals

Registry

Crossref · 10.1038/nature00786

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Global Burden of Cardiovascular Diseases
Yusuf, S., Reddy, S., Ôunpuu, S., & Anand, S. S. (2001) · Circulation · doi:10.1161/hc4601.099487 · Cited by 3,014
Handbook of Proteolytic Enzymes
(2004) · Elsevier eBooks · doi:10.1016/c2009-0-03628-9 · Cited by 2,623
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
Garg, R. (1995) · JAMA · doi:10.1001/jama.273.18.1450 · Cited by 1,993
Essential Hypertension
Carretero, O. A., & Oparil, S. (2000) · Circulation · doi:10.1161/01.cir.101.3.329 · Cited by 1,155
The Handbook of proteolytic enzymes
Barrett, A. J., Rawlings, N. D., & Woessner, J. F. (1998) · Cited by 1,119
The Berkeley Drosophila Genome Project Gene Disruption Project: Single P-Element Insertions Mutating 25% of Vital Drosophila Genes
Spradling, A. C., Stern, D., Beaton, A., Rehm, E. J., Laverty, T., Mozden, N., Misra, S., & Rubin, G. M. (1999) · Genetics · doi:10.1093/genetics/153.1.135 · Cited by 781

Flagged first, then by citations

Show all 44 references

1 of the 44 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 999

ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
Sriramula, S., Cardinale, J. P., Lazartigues, E. D., & Francis, J. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr242 · Cited by 186
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
Xiao, L., Sakagami, H., & Miwa, N. (2020) · Viruses · doi:10.3390/v12050491 · Cited by 193
Angiotensin-converting Enzyme 2 (ACE2), But Not ACE, Is Preferentially Localized to the Apical Surface of Polarized Kidney Cells
Warner, F. J., Lew, R. A., Smith, A. I., Lambert, D., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508914200 · Cited by 182
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor
Davidson, A. M., Wysocki, J. A., & BATLLE, D. C. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15256 · Cited by 183
ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes
Tikellis, C., Bialkowski, K., Pete, J., Sheehy, K., Qui, S., Johnston, C. I., Cooper, M. E., & Thomas, M. C. (2008) · Diabetes · doi:10.2337/db07-1212 · Cited by 181
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 194
Overexpression of Angiotensin-Converting Enzyme 2 in the Rostral Ventrolateral Medulla Causes Long-Term Decrease in Blood Pressure in the Spontaneously Hypertensive Rats
Yamazato, M., Yamazato, Y., Sun, C., Díez-Freire, C., & Raizada, M. K. (2007) · Hypertension · doi:10.1161/01.hyp.0000259942.38108.20 · Cited by 180
Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
Tikoo, K., Patel, G. A., Kumar, S., Karpe, P. A., Sanghavi, M., Malek, V., & Srinivasan, K. K. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.013 · Cited by 177
Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure
Kittleson, M. M., Minhas, K. M., Irizarry, R. A., Ye, S. Q., Edness, G., Breton, E., Conte, J. V., Tomaselli, G. F., Garcia, J. G. N., & Hare, J. M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00255.2004 · Cited by 173
ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease
Rabelo, L. A., Alenina, N. V., & Bäder, M. (2010) · Hypertension Research · doi:10.1038/hr.2010.235 · Cited by 173
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection
Penninger, J. M., Grant, M. B., & Sung, J. J. �. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.067 · Cited by 178
Self-citation
Therapeutic Implications of the Vasoprotective Axis of the Renin-Angiotensin System in Cardiovascular Diseases
Ferreira, A. J., Santos, R. A. S., Bradford, C., Mecca, A. P., Sumners, C., Katovich, M. J., & Raizada, M. K. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.140145 · Cited by 171
ACE2 expression and activity are enhanced during pregnancy
Levy, A., Yagil, Y., Bursztyn, M., Barkalifa, R., Scharf, S., & Yagil, C. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90592.2008 · Cited by 168
Self-citation
Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas With AT 1 and AT 2 Receptors in the Mouse Heart
Castro, C. H., Santos, R. A. S., Ferreira, A. J., Bäder, M., Alenina, N. V., & Almeida, A. P. (2005) · Hypertension · doi:10.1161/01.hyp.0000175813.04375.8a · Cited by 168
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
Sanchis‐Gomar, F., Lavie, C. J., Pérez-Quilis, C., Henry, B. M., & Lippi, G. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.026 · Cited by 167
ACE2: A New Target for Cardiovascular Disease Therapeutics
Raizada, M. K., & Ferreira, A. J. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3180986219 · Cited by 164
Recent advances involving the renin–angiotensin system
Crowley, S. D., & Coffman, T. M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.023 · Cited by 172
Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)
Tallant, E. A., & Clark, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000090322.55782.30 · Cited by 167
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
Narula, S., Yusuf, S., Chong, M., Ramasundarahettige, C. F., Rangarajan, S., Bangdiwala, S. I., van Eickels, M., Leineweber, K., Wu, A., Pigeyre, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31964-4 · Cited by 169
The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction
Schmaier, A. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00535.2002 · Cited by 170
Cardiovascular actions of angiotensin-(1-7)
Ferreira, A. J., & Santos, R. A. S. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000400003 · Cited by 165
FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1–7) Axis in Mice
Pan, X., Shao, Y., Wu, F., Wang, Y., Xiong, R., Zheng, J., Tian, H., Wang, B., Wang, Y., Zhang, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.002 · Cited by 163
Angiotensin-converting enzyme 2 is a key modulator of the renin–angiotensin system in cardiovascular and renal disease
Tikellis, C., Bernardi, S., & Burns, W. C. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328341164a · Cited by 163
ACE and ACE2 in Inflammation: A Tale of Two Enzymes
Gaddam, R. R., Chambers, S. T., & Bhatia, M. (2014) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528113666140713164506 · Cited by 165
Improved Lipid and Glucose Metabolism in Transgenic Rats With Increased Circulating Angiotensin-(1-7)
Santos, S. H. S., Braga, J. F., Mário, É. G., Pôrto, L. C. J., Rodrigues‐Machado, M. D. G., Murari, A., Botion, L. M., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.200493 · Cited by 162
COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
Moccia, F. D., Gerbino, A., Lionetti, V., Miragoli, M., Munaron, L., Pagliaro, P., Pasqua, T., Penna, C. R. R., Rocca, C., Samaja, M., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00198-w · Cited by 165
The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19
Ye, Q., Wang, B., Zhang, T., Xu, J., & Shang, S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00148.2020 · Cited by 162
SARS-CoV-2: characteristics and current advances in research
Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 168
ACE2, angiotensin-(1–7), and Mas: the other side of the coin
Bäder, M. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1120-0 · Cited by 160
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
Mendoza‐Torres, E., Oyarzún, A. P., Mondaca‐Ruff, D., Azócar, A. A., Castro, P., Jalil, J., Chiong, M., Lavandero, S., & Ocaranza, M. P. (2015) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944715597623 · Cited by 157
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
Bosso, M., Thanaraj, T. A., Abu‐Farha, M., Alanbaei, M., Abubaker, J. A., & Al‐Mulla, F. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.017 · Cited by 159
Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
Ingraham, N. E., Barakat, A., Reilkoff, R. A., Bezdicek, T. L., Schacker, T. W., Chipman, J. G., Tignanelli, C. J., & Puskarich, M. A. (2020) · European Respiratory Journal · doi:10.1183/13993003.00912-2020 · Cited by 161
Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System
Brojakowska, A., Narula, J., Shimony, R. Y., & Bander, J. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.028 · Cited by 158
Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain
Becker, L. K., Etelvino, G. M., Walther, T., Santos, R. A. S., & Campagnole‐Santos, M. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00141.2007 · Cited by 155
Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis
Herath, C. B., Warner, F. J., Lubel, J. S., Dean, R. G., Jia, Z., Lew, R. A., Smith, A. I., Burrell, L. M., & Angus, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.008 · Cited by 154
What’s new in the renin-angiotensin system?
Warner, F. J., Smith, A. I., Hooper, N. M., & Turner, A. J. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4240-7 · Cited by 156
Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2
Shajahan, A., Archer‐Hartmann, S. A., Supekar, N. T., Gleinich, A. S., Heiß, C., & Azadi, P. (2020) · Glycobiology · doi:10.1093/glycob/cwaa101 · Cited by 148
The ANG-(1–7)/ACE2/mas axis in the regulation of nephron function
Ferrario, C. M., & Varagić, J. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00110.2010 · Cited by 151
Self-citation
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
Cenko, E., Badimón, L., Bugiardini, R., Claeys, M. J., Luca, G. D., de Wit, C., Dérumeaux, G., Dorobanţu, M., Duncker, D. J., Eringa, E. C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab298 · Cited by 152
Angiotensin II receptors and drug discovery in cardiovascular disease
Dasgupta, C., & Zhang, L. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.016 · Cited by 158
Self-citation
Just the Beginning: Novel Functions for Angiotensin-Converting Enzymes
Eriksson, U., Danilczyk, U. G., & Penninger, J. M. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01255-1 · Cited by 148
Self-citation
New insights and perspectives on intrarenal renin-angiotensin system: Focus on intracrine/intracellular angiotensin II
Zhuo, J. L., & Li, X. C. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.012 · Cited by 149
The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice
Wang, X., Ye, Y., Gong, H., Wu, J., Yuan, J., Wang, S., Yin, P., Ding, Z., Kang, L., Qiu, J., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.012 · Cited by 147
Mechanisms of Diabetic Nephropathy
Giunti, S., Barit, D., & Cooper, M. E. (2006) · Hypertension · doi:10.1161/01.hyp.0000240331.32352.0c · Cited by 148
Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology
Sarkissian, S. D., Grobe, J. L., Yuan, L., Narielwala, D. R., Walter, G. A., Katovich, M. J., & Raizada, M. K. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100693 · Cited by 144
Evidence for treatment with estradiol for women with SARS-CoV-2 infection
Seeland, U., Coluzzi, F., Simmaco, M., Mura, C., Bourne, P. E., Heiland, M., Preißner, R., & Preißner, S. (2020) · BMC Medicine · doi:10.1186/s12916-020-01851-z · Cited by 150
ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage
Sato, T., Sato, C., Kadowaki, A., Watanabe, H., Ho, L., Ishida, J., Yamaguchi, T., Kimura, A., Fukamizu, A., Penninger, J. M., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx061 · Cited by 143
Self-citation
Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection
Trottein, F., & Sokol, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107915 · Cited by 141
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubules
Li, N., Zimpelmann, J., Cheng, K., Wilkins, J. A., & Burns, K. D. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00144.2004 · Cited by 143
Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling
McKinney, C. A., Fattah, C., Loughrey, C. M., Milligan, G., & Nicklin, S. A. (2014) · Clinical Science · doi:10.1042/cs20130436 · Cited by 142
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
Shirbhate, E., Pandey, J., Patel, V. K., Kamal, M., Jawaid, T., Gorain, B., Kesharwani, P., & Rajak, H. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00303-6 · Cited by 164
Genetically altered animal models for Mas and angiotensin‐(1–7)
Alenina, N. V., Xu, P., Rentzsch, B., Patkin, E. L., & Bäder, M. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2007.040345 · Cited by 142
Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144
The renin–angiotensin system in retinal health and disease: Its influence on neurons, glia and the vasculature
Fletcher, E. L., Phipps, J. A., Ward, M. M., Vessey, K. A., & Wilkinson‐Berka, J. L. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.003 · Cited by 143
Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II
Shaltout, H. A., Westwood, B. M., Averill, D. B., Ferrario, C. M., Figueroa, J. P., Diz, D. I., Rose, J. C., & Chappell, M. C. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00139.2006 · Cited by 141
Self-citation
From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
Patel, S. K., Velkoska, E., Freeman, M., Wai, B., Lancefield, T. F., & Burrell, L. M. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00227 · Cited by 138
Targeting TMPRSS2 in SARS-CoV-2 Infection
Baughn, L. B., Sharma, N., Elhaik, E., Sekulić, A., Bryce, A. H., & Fonseca, R. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.018 · Cited by 141
The Renin-Angiotensin System and Diabetic Nephropathy
Gurley, S. B., & Coffman, T. M. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.009 · Cited by 137
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models
Alenina, N. V., & Bäder, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2679-4 · Cited by 145
Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
Kuba, K., Imai, Y., Rao, S., Jiang, C., & Penninger, J. M. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0094-9 · Cited by 138
Self-citation
Potential role of ACE2 in coronavirus disease 2019 (COVID-19) prevention and management
Liu, M., Wang, T., Zhou, Y., Zhao, Y., Zhang, Y., & Li, J. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0003 · Cited by 137
Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator
Bian, J., & Li, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.006 · Cited by 148
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies
Albini, A., Guardo, G. D., Noonan, D. M., & Lombardo, M. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02364-6 · Cited by 138
ACE2 Activation Promotes Antithrombotic Activity
Fraga-Silva, R. A., Sorg, B. S., Wankhede, M., deDeugd, C. M., Jun, J. Y., Baker, M. B., Li, Y., Castellano, R. K., Katovich, M. J., Raizada, M. K., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00160 · Cited by 133
Angiotensin-Converting Enzyme 2 — A New Cardiac Regulator
Boehm, M., & Nabel, E. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr022472 · Cited by 132
Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
Agata, J., Ura, N., Yoshida, H., Shinshi, Y., Sasaki, H., Hyakkoku, M., Taniguchi, S., & Shimamoto, K. (2006) · Hypertension Research · doi:10.1291/hypres.29.865 · Cited by 132
Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs
Santos, R. A. S., Ferreira, A. J., Pinheiro, S. V. B., Sampaio, W. O., Touyz, R. M., & Campagnole‐Santos, M. J. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.8.1019 · Cited by 132
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #
Österreicher, C. H., Taura, K., Minicis, S. D., Seki, E., Penz-Österreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23104 · Cited by 133
Self-citation
Cardiac Angiotensin-(1-7) in Ischemic Cardiomyopathy
Averill, D. B., Ishiyama, Y., Chappell, M. C., & Ferrario, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000092888.63239.54 · Cited by 132
Self-citation
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome
Imai, Y., Kuba, K., & Penninger, J. M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6228-6 · Cited by 131
Self-citation
Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic
Oudit, G. Y., Wang, K., Viveiros, A., Kellner, M. J., & Penninger, J. M. (2023) · Cell · doi:10.1016/j.cell.2023.01.039 · Cited by 136
Self-citation
Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats
Dalpiaz, P. L. M., Lamas, A. Z., Caliman, I. F., Ribeiro, E. H., Abreu, G. R., Moysés, M. R., de Andrade, T. U., Gouvêa, S. A., Alves, M. F. M., Carmona, A. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127515 · Cited by 129
SARS-CoV-2 and cardiovascular complications: From molecular mechanisms to pharmaceutical management
Wu, L., O’Kane, A., Hu, P., Bi, Y., Motriuk-Smith, D., & Ren, J. T. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114114 · Cited by 132
Upregulation of Angiotensin-Converting Enzyme 2 by All- trans Retinoic Acid in Spontaneously Hypertensive Rats
Zhong, J., Huang, D., Yang, Y., Li, Y., Liu, G., Song, X., & Du, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000146400.57221.74 · Cited by 129
Enhanced Renal Immunocytochemical Expression of ANG-(1-7) and ACE2 During Pregnancy
Brosnihan, K. B., Neves, L. A. A., Joyner, J., Averill, D. B., Chappell, M. C., Sarao, R., Penninger, J. M., & Ferrario, C. M. (2003) · Hypertension · doi:10.1161/01.hyp.0000085220.53285.11 · Cited by 128
Self-citation
Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis
Wu, T., Zuo, Z., Kang, S., Jiang, L., Luo, X., Xia, Z., Liu, J., Xiao, X., Ye, M., & Deng, M. (2020) · Aging and Disease · doi:10.14336/ad.2020.0520 · Cited by 126
Mechanism of High Glucose–Induced Angiotensin II Production in Rat Vascular Smooth Muscle Cells
Lavrentyev, E. N., Estes, A. M., & Malik, K. U. (2007) · Circulation Research · doi:10.1161/circresaha.107.151852 · Cited by 128
Nonclassical Renin‐Angiotensin System and Renal Function
Chappell, M. C. (2012) · Comprehensive physiology · doi:10.1002/cphy.c120002 · Cited by 128
Self-citation
Angiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives
Iusuf, D., Henning, R. H., van Gilst, W. H., & Roks, A. J. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.090 · Cited by 127
Tissue renin angiotensin systems
Ré, R. N. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00124-x · Cited by 125
ACE2: Angiotensin II/Angiotensin-(1–7) Balance in Cardiac and Renal Injury
Varagić, J., Ahmad, S., Nagata, S., & Ferrario, C. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0420-5 · Cited by 126
Self-citation
Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy
BATLLE, D. C., Wysocki, J. A., Soler, M. J., & Ranganath, K. (2011) · Kidney International · doi:10.1038/ki.2011.381 · Cited by 126
Cardioprotective Effects of Telmisartan against Heart Failure in Rats Induced By Experimental Autoimmune Myocarditis through the Modulation of Angiotensin-Converting Enzyme-2/Angiotensin 1-7/Mas Receptor Axis
Sukumaran, V., Veeraveedu, P. T., Gurusamy, N., Yamaguchi, K., Lakshmanan, A. P., Ma, M., Suzuki, K., Kodama, M., & Watanabe, K. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1077 · Cited by 126
Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
Liu, C. X., Hu, Q., Wang, Y., Zhang, W., Ma, Z. Y., Feng, J. B., Wang, R., Wang, X. P., Dong, B., Gao, F., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00111 · Cited by 126
ACE2 alterations in kidney disease
Soler, M. J., Wysocki, J. A., & BATLLE, D. C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft320 · Cited by 127
Identification of critical active‐site residues in angiotensin‐converting enzyme‐2 (ACE2) by site‐directed mutagenesis
Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M., & Turner, A. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04756.x · Cited by 123
ACE2 and Diabetes: ACE of ACEs?
BATLLE, D. C., Soler, M. J., & Ye, M. (2010) · Diabetes · doi:10.2337/db10-1205 · Cited by 125
ACE2 Cell Biology, Regulation, and Physiological Functions
Turner, A. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801364-9.00025-0 · Cited by 134
Interferon-γ and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells
de Lang, A., Osterhaus, A. D. M. E., & Haagmans, B. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.011 · Cited by 123
The flexibility of ACE2 in the context of SARS-CoV-2 infection
de Barros, E. P., Casalino, L., Gaieb, Z., Dommer, A. C., Wang, Y., Fallon, L., Raguette, L. E., Belfon, K. A. A., Simmerling, C. L., & Amaro, R. E. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.036 · Cited by 120
ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function
Xia, H., Suda, S., Bindom, S. M., Feng, Y., Gurley, S. B., Seth, D. M., Navar, L. G., & Lazartigues, E. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022682 · Cited by 122
miRNA-200c-3p is crucial in acute respiratory distress syndrome
Liu, Q., Du, J., Yu, X., Xu, J., Huang, F., Li, X., Zhang, C., Li, X., Chang, J., Shang, D., et al. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.21 · Cited by 124
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 126
Self-citation
Statins: Could an old friend help in the fight against COVID‐19?
Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Márquez‐Expósito, L., Rayego‐Mateos, S., Santos‐Sanchez, L., Marchant, V. A., Tejedor-Santamaria, L., Ramos, A. M., Ortíz, A., Egido, J., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15166 · Cited by 121
Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
Terada, M., Ohtsu, H., Saito, S., Hayakawa, K., Tsuzuki, S., Asai, Y., Matsunaga, N., Kutsuna, S., Sugiura, W., & Ohmagari, N. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047007 · Cited by 121
Impact of ACE2 Deficiency and Oxidative Stress on Cerebrovascular Function With Aging
Silva, R. A. P., Chu, Y., Miller, J. D., Mitchell, I. J., Penninger, J. M., Faraci, F. M., & Heistad, D. D. (2012) · Stroke · doi:10.1161/strokeaha.112.667063 · Cited by 122
Self-citation
A local pancreatic renin-angiotensin system: endocrine and exocrine roles
Leung, P. S., & Chappell, M. C. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00179-6 · Cited by 119
Self-citation
Sex Differences in the Effectiveness of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Congestive Heart Failure — A Population Study
Hudson, M., Rahme, E., Behlouli, H., Sheppard, R. J., & Pilote, L. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.02.001 · Cited by 117
Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy
Liu, Z., Huang, X. R., Chen, H., Penninger, J. M., & Lan, H. Y. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.2 · Cited by 115
Self-citation
Sex differences in circulating and renal angiotensins of hypertensive mRen().Lewis but not normotensive Lewis rats
Pendergrass, K. D., Pirro, N. T., Westwood, B. M., Ferrario, C. M., Brosnihan, K. B., & Chappell, M. C. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01277.2007 · Cited by 116
Self-citation

Authors: Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., Scholey, J., Ferrario, C. M., Manoukian, A. S., Chappell, M. C., Backx, P. H., Yagil, Y., & Penninger, J. M.
Affiliations: University of Toronto (CA)
Institute of Molecular Biotechnology (AT)
University Health Network (CA)
Barzilai Medical Center (IL)
Atrium Health Wake Forest Baptist (US)
Corresponding author: Penninger, Josef M.
ORCID: Crackower, Michael A.
Oudit, Gavin Y.
Kozieradzki, Ivona
Zhang, Liyong
Pei, York
Scholey, James
Ferrario, Carlos M.
Chappell, Mark C.
Backx, Peter H.
Yagil, Yoram
Penninger, Josef M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2002-06
Volume: 417
Issue: 6891
Pages: 822-828
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature00786
OpenAlex: W2025672718
Cited by: 1,733
References: 44
Citations by year: 2026: 12 · 2025: 25 · 2024: 38 · 2023: 88 · 2022: 117 · 2021: 215 · 2020: 311 · 2019: 38 · 2018: 22 · 2017: 33 · 2016: 42 · 2015: 38 · 2014: 53 · 2013: 54 · 2012: 60
FWCI: 38.64
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amgen
German-Israeli Foundation for Scientific Research and Development
Canada Research Chairs
Israel Science Foundation
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Keywords: angiotensin-converting enzyme 2, ACE2, cardiac function, hypertension, quantitative trait loci, X chromosome, cardiac contractility, angiotensin II, hypoxia, Acer, cardiac morphogenesis, rat model, mouse knockout
MeSH terms: Angiotensin II, Animals, Hypoxia, Blood Pressure, Cloning, Molecular, Drosophila melanogaster, Female, Heart, Hypertension, Peptidyl-Dipeptidase A, Male, Metalloendopeptidases, Myocardial Contraction, Myocardium, X Chromosome, Up-Regulation, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Quantitative Trait, Heritable, Radiation Hybrid Mapping, Drosophila Proteins, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin-converting enzyme 2 is an essential regulator of heart function

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks